MARKET

TALS

TALS

Talaris Therapeutics, Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

16.25
-0.75
-4.41%
After Hours: 16.19 -0.06 -0.37% 18:55 05/07 EDT
OPEN
17.25
PREV CLOSE
17.00
HIGH
17.50
LOW
16.01
VOLUME
2.94M
TURNOVER
--
52 WEEK HIGH
17.50
52 WEEK LOW
16.01
MARKET CAP
670.10M
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
Talaris Therapeutics Shares Fall in Stock Market Debut
MT Newswires · 2d ago
IPOs For Friday, May 7: Bowman Consulting Group, Priced At $14/Share; Anebulo Pharmaceuticals, Priced At $7/Share; Data Knights Acquisition Corp., Priced At $10/Unit; Talaris Therapeutics, Priced At $17/Share
(NASDAQ:ANEB) (NASDAQ:DKDCU)  
Benzinga · 2d ago
DJ Talaris Therapeutics IPO Priced at Middle of Expectations >TALS
Dow Jones · 2d ago
Talaris Therapeutics prices 8.8M-share IPO at $17
Talaris Therapeutics (TALS) has priced its IPO of 8.825M shares of common stock at $17.00/share.Expected gross proceeds are ~$150M.Trading kicks off on May 7.Underwriters' over-allotment is an additional ~1.32M shares.Morgan
Seekingalpha · 2d ago
Talaris Therapeutics Prices IPO at $17/Share, Expects $150 Million Gross Proceeds
MT Newswires · 2d ago
No Data
Learn about the latest financial forecast of TALS. Analyze the recent business situations of Talaris Therapeutics, Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.53%
Pharmaceuticals & Medical Research
+1.04%
Key Executives
Chief Executive Officer/Director
Scott Requadt
Founder/Chief Scientific Officer/Director
Suzanne Ildstad
Chief Financial Officer/Primary Contact
Gregg Beloff
Vice President
Roderick Purdy
Other
Nancy Krieger
No Data
About TALS
Talaris Therapeutics, Inc. is a United States-based company operates as a biotechnology company. The Company offers single-dose cell therapies, kidney transplants, and clinical trials.

Webull offers kinds of Talaris Therapeutics Inc stock information, including NASDAQ:TALS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TALS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TALS stock methods without spending real money on the virtual paper trading platform.